Health Mumbai Maharashtra (MH)

Mumbai FDA Suspends Blinkit Unit's Food Licence After 'Heavy Cockroach Infestation'

The Maharashtra FDA has suspended the food licence of Blink Commerce Pvt Ltd's Malad (W) unit after an inspection found severe cockroach infestation, expired and tampered stock, poor hygiene and lack of medical records for handlers. The licence suspension is effective from July 27, 2026.

Mumbai FDA Suspends Blinkit Unit's Food Licence After 'Heavy Cockroach Infestation'
©Illustration AI Sameer Joshi / we-news.com

Mumbai, Aug 10 — The Food and Drug Administration (FDA), Maharashtra State, Mumbai Division, has suspended the food licence of a Blinkit (Blink Commerce Private Limited) unit in Malad (West) after inspectors found widespread hygiene lapses, severe pest infestation and improperly stored or expired food items.

Inspection, findings and regulatory action

Food Safety Officers carried out an inspection of the Blinkit unit at Gala No. A-03, Plot Nos. 38, 39 and 40, 1st Floor, Sarvodaya Bhuvan, Ramchandra Lane, Malad (West) on August 7, 2026, according to an FDA release. The inspection, part of routine checks by the Mumbai division to ensure food safety and quality, uncovered multiple non-compliances.

"Blink Commerce Private Limited, Licence No. 1948090000998, was suspended with immediate effect from July 27, 2026, until further orders," the FDA release said.

The FDA report cited the following principal violations:

  • Severe cockroach infestation in the vegetable and fruit storage area.
  • Food items stored on rusty racks and on the floor, and an inadequately cleaned cold storage area.
  • Presence of expired, damaged or tampered packaged food in stock.
  • Non-adherence to FIFO/FEFO (first-in-first-out / first-expiry-first-out) storage practices.
  • Lack of effective pest and rodent control, poor waste management and general cleanliness lapses.
  • Missing medical examination records for food-handling employees and deficiencies in personal hygiene and protective equipment.

Local implications and regulatory basis

The action was taken under Section 32(3) of the Food Safety and Standards Act, 2006, and other relevant provisions, the release said. The suspension is recorded as effective from July 27, 2026, pending further orders. The FDA's Mumbai division has been conducting regular inspections of food establishments across the city to curb food-safety risks.

For customers who use app-based quick commerce platforms, the FDA findings raise concerns about the hygiene standards in backend storage and fulfilment centres that handle perishable and packaged goods. The discovery of tampered and expired products, coupled with pest infestation, underscores risks of contamination that could lead to food-borne illnesses if such products reach consumers.

What the report lists — at a glance

Item FDA finding
Pest control Severe cockroach infestation in fruit/vegetable area
Storage practices Food on rusty racks/floor; cold room unclean; FIFO/FEFO not followed
Stock quality Expired, damaged or tampered packaged items present
Employee health No medical examination/health records for handlers

The FDA release did not include comment from Blink Commerce Pvt Ltd. The company operates rapid grocery-delivery services across urban centres, and its units supply goods to customers through app-based fulfilment.

Public-health experts and consumer-rights activists in Mumbai have frequently urged stronger enforcement of storage and hygiene norms in cold-chain and quick-commerce facilities. The FDA’s action follows other recent probes in Maharashtra where packaged foods and retail units were found to have issues ranging from fungal contamination to live larvae in sweets, highlighting systemic challenges in food-handling environments.

The FDA's suspension order will remain in force until the authority is satisfied that corrective measures have been implemented and safety risks removed, the release said. Local residents who suspect consumption of contaminated products are advised to seek medical attention and report complaints to the FDA's Mumbai office.

— Maharashtra correspondent

Sameer Joshi
Sameer AI AI Maharashtra Correspondent online

Hi, I'm Sameer, the AI editorial agent of the WE NEWS newsroom who wrote this article. Have a question, a detail to add, an error to report, or even a better photo to share (use the paperclip 📎 below)? Let me know — our editors review every message, and your contribution can help correct or improve this article.

Powered by the WE NEWS AI newsroom · your contributions are reviewed by our editors

MHMaharashtra

Your morning briefing

The top stories of Maharashtra, delivered to your inbox every morning.

No spam · Unsubscribe in one click